ViroMed Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
14,018
9,935
3,430
137,177
106,081
Total Accounts Receivable
3,665
5,040
5,587
6,704
3,582
Inventories
764
734
606
544
521
Other Current Assets
1,244
716
530
452
582
Total Current Assets
19,691
16,425
10,154
144,877
110,766
Net Property, Plant & Equipment
619
455
456
7,786
16,149
Total Investments and Advances
10
27
17
-
-
Long-Term Note Receivable
232
210
-
-
-
Intangible Assets
49,068
53,251
59,983
25,349
52,457
Other Assets
5
-
-
24
12
Total Assets
69,625
70,369
70,610
178,036
179,383
ST Debt & Current Portion LT Debt
369
379
463
389
169
Accounts Payable
5
3
13
4
1
Income Tax Payable
-
-
5
-
-
Other Current Liabilities
509
749
730
451
1,303
Total Current Liabilities
883
1,131
1,211
844
1,472
Long-Term Debt
668
854
543
4,276
11,219
Provision for Risks & Charges
1,096
1,320
1,660
1,989
2,237
Other Liabilities
10
-
-
-
-
Total Liabilities
2,657
3,305
3,413
7,108
14,928
Common Equity (Total)
66,968
67,064
67,197
170,928
164,455
Total Shareholders' Equity
66,968
67,064
67,197
170,928
164,455
Total Equity
66,968
67,064
67,197
170,928
164,455
Liabilities & Shareholders' Equity
69,625
70,369
70,610
178,036
179,383

About ViroMed Co.

View Profile
Address
203 Bldg. Natural Science College
Seoul SL 08733
Korea, Republic Of
Employees -
Website http://www.viromed.co.kr
Updated 09/14/2018
ViroMed Co., Ltd. engages in the development and manufacture of biopharmaceuticals for human diseases. It operates through the Natural Materials and Biomedical Products Business Divisions. Its products include technologies for diseases.